HEXIM1 down-regulates hypoxia-inducible factor-1α protein stability

Area of Science:

• Molecular Biology
• Cancer Biology
• Cellular Signaling

Background:

• HEXIM1 (Hexamethylene-bis-acetamide-inducible protein 1) inhibits hypoxia-inducible factor α (HIF-1α)-regulated pathways.
• Disrupted HEXIM1 activity in mice increases mammary tumor susceptibility via upregulated VEGF, HIF-1α, and aberrant vascularization.

Purpose of the Study:

• To elucidate the mechanistic basis of HEXIM1's regulation of HIF-1α.
• To understand how HEXIM1 influences HIF-1α protein stability and downstream signaling.

Main Methods:

• Investigated direct interactions between HIF-1α and HEXIM1.
• Assessed HEXIM1's effect on HIF-1α hydroxylation, ubiquitination, and degradation.
• Examined HEXIM1's role in regulating PHD3 and HDAC1 interactions with HIF-1α.
• Analyzed the impact of HEXIM1 on HIF-1α target gene expression, including VEGF.

Main Results:

• HEXIM1 directly interacts with HIF-1α and promotes its hydroxylation via induced PHD3 expression.
• HEXIM1 facilitates HIF-1α interaction with pVHL, leading to ubiquitination and proteasomal degradation.
• HEXIM1 attenuates HIF-1α interaction with HDAC1, promoting HIF-1α acetylation.
• Down-regulation of HEXIM1 leads to increased HIF-1α protein expression and target gene activation, promoting cell invasion.

Conclusions:

• HEXIM1 negatively regulates HIF-1α protein stability through hydroxylation and degradation pathways.
• HEXIM1's regulation of HIF-1α impacts VEGF expression, vascularization, and tumor development.
• Understanding this mechanism provides insights into targeting HIF-1α for cancer therapy.